PAD 0193 Pill: white, capsule/oblong, 19mm
The pill with imprint PAD 0193 (White, Capsule/Oblong, 19mm) has been identified as Indomethacin Extended Release 75 mg and is used for Back Pain, Bursitis, Ankylosing Spondylitis, Bartter Syndrome, and Cluster Headaches. It belongs to the drug class Nonsteroidal anti-inflammatory drugs and is not a controlled substance.
Images for PAD 0193
Indomethacin Extended Release
- Imprint
- PAD 0193
- Strength
- 75 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Paddock Laboratories, Inc.
- National Drug Code (NDC)
- 00574-0193 (Discontinued)
- Inactive Ingredients
-
carboxymethylcellulose sodium,
gelatin,
lactose monohydrate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
See also:
More about indomethacin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (211)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
Patient resources
- Indomethacin drug information
- Indomethacin rectal
- Indomethacin (Intravenous) (Advanced Reading)
- Indomethacin Capsules
- Indomethacin Extended-Release Capsules
- Indomethacin Suppositories
Other brands
Professional resources
- Indomethacin monograph
- Indomethacin (FDA)
- Indomethacin ER (FDA)
- Indomethacin Injection (FDA)
- Indomethacin Oral Suspension (FDA)
- Indomethacin Suppository (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.